Vasonatrin peptide stimulates both of the natriuretic peptide receptors, NPRA and NPRB

Biochemical and Biophysical Research Communications

Volumn 446, Issue 4, 2014, Pages 1276-1280

  Jiang, Y S ^a   Lei, J Y ^a   Chen, Y ^a   Jin, J ^a,b  

^a JIANGNAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Binding affinity; Molecular dynamics; Natriuretic peptide; Natriuretic peptide receptor; Vasonatrin peptide

Indexed keywords

BINDING AFFINITY; MOLECULAR DYNAMICS; NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE RECEPTOR; VASONATRIN PEPTIDE;

ATRIAL NATRIURETIC FACTOR; BINDING SITES; HEK293 CELLS; HUMANS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 84899492118     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.110     Document Type: Article

References (24)

1. G. Boerrigter, L.C. Costello-Boerrigter, and J.C. Burnett Jr. Natriuretic peptides in the diagnosis and management of chronic heart failure Heart Fail. Clin. 5 2009 501 514
2. T.G. Flynn, M.L. de Bold, and A.J. de Bold The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties Biochem. Biophys. Res. Commun. 117 1983 859 865
3. T. Sudoh, K. Kangawa, N. Minamino, and H. Matsuo A new natriuretic peptide in porcine brain Nature 332 1988 78 81
4. T. Sudoh, N. Minamino, K. Kangawa, and H. Matsuo C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain Biochem. Biophys. Res. Commun. 168 1990 863 870
5. L.R. Potter, A.R. Yoder, D.R. Flora, L.K. Antos, and D.M. Dickey Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications Handb. Exp. Pharmacol. 2009 341 366
6. Y. Cho, B.G. Somer, and A. Amatya Natriuretic peptides and their therapeutic potential Heart Dis. 1 1999 305 328
7. C.M. Wei, C.H. Kim, V.M. Miller, and J.C. Burnett Jr. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide J. Clin. Invest. 92 1993 2048 2052
8. H.S. Feng, Y.M. Zang, M.Z. Zhu, J.M. Pei, Y.M. Wang, L. Wang, and P.T. Shi Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide Sheng Li Xue Bao 51 1999 515 520
9. M.Q. Dong, M.Z. Zhu, J. Yu, L.J. Shang, and H.S. Feng Comparison of inhibitory effects of three natriuretic peptides on the proliferation of pulmonary artery smooth muscle cells of rats Sheng Li Xue Bao 52 2000 252 254
10. S.Y. Lu, M.Z. Zhu, D.S. Wang, S.Y. Chen, W.D. Zhang, H. Dong, J. Yu, and H.T. Guo Inhibition of the proliferation of smooth muscle cells from human coronary bypass vessels by vasonatrin peptide Physiol. Res. 53 2004 387 393
11. S.Y. Lu, M.Z. Zhu, H.T. Guo, J. Yu, and Q.M. Wei Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes Sheng Li Xue Bao 54 2002 7 11
12. S.Y. Lu, D.S. Wang, M.Z. Zhu, Q.H. Zhang, Y.Z. Hu, and J.M. Pei Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells Life Sci. 77 2005 28 38
13. Y. Morishita, T. Sano, K. Ando, Y. Saitoh, H. Kase, K. Yamada, and Y. Matsuda Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor Biochem. Biophys. Res. Commun. 176 1991 949 957
14. L.R. Potter, S. Abbey-Hosch, and D.M. Dickey Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions Endocr. Rev. 27 2006 47 72
15. M.B. Anand-Srivastava Natriuretic peptide receptor-C signaling and regulation Peptides 26 2005 1044 1059
16. G.E. Woodard, X. Li, J. Brown, and J.A. Rosado Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries Regul. Pept. 129 2005 183 189
17. B.Y. Chen, J.K. Chen, M.Z. Zhu, D.L. Zhang, J.S. Sun, J.M. Pei, H.S. Feng, X.X. Zhu, J. Jin, and J. Yu AC-NP: a novel chimeric peptide with natriuretic and vasorelaxing actions PLoS One 6 2011 e20477
18. O. Lisy, and J.C. Burnett The design, synthesis and cardiorenal actions of a new chimeric natriuretic peptide CD-NP J. Am. Coll. Cardiol. 41 2003 312a-312a
19. D.M. Dickey, J.C. Burnett Jr., and L.R. Potter Novel bifunctional natriuretic peptides as potential therapeutics J. Biol. Chem. 283 2008 35003 35009
20. D. Muller, B. Hida, G. Guidone, R.C. Speth, T.V. Michurina, G. Enikolopov, and R. Middendorff Expression of guanylyl cyclase (GC)-A and GC-B during brain development: evidence for a role of GC-B in perinatal neurogenesis Endocrinology 150 2009 5520 5529
21. B.Y. Chen, P. Qu, R. Tie, M.Z. Zhu, X.X. Zhu, and J. Yu Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis Regul. Pept. 164 2010 139 143
22. B.Y. Chen, R. Tie, P. Qu, M.Z. Zhu, X.X. Zhu, J. Jin, and J. Yu Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes J. Endocrinol. Invest. 34 2011 742 746
23. X. Zhu, Y. Wang, A. Schwiebs, and T. Walther Chimeric natriuretic peptide ACNP stimulates both natriuretic peptide receptors, the NPRA and NPRB Mol. Cell. Endocrinol. 366 2013 117 123
24. D.M. Dickey, D.R. Flora, P.M. Bryan, X. Xu, Y. Chen, and L.R. Potter Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, not NPR-A, is the predominant natriuretic peptide receptor in the failing heart Endocrinology 148 2007 3518 3522